Delivery Order SPE2DB20D1109-SPE2DB24FN51F
Award Date
1/29/24
Potential Completion Date
1/30/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,140.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GADAVIST 1 MMOL/ML BULK VIAL 30ML. The award is a delivery order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award, valued at $4,562.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of GADAVIST 10 MMOL/10 ML VIAL 10ML, a medical product, with a performance period ending on March 13, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has established itself as a key vendor for federal healthcare programs,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,942.00 Firm Fixed Price Delivery Order is for the pharmaceutical product GADAVIST 10 MMOL/10 ML VIAL 10ML. The award has an ultimate completion date of January 11, 2024 and was not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $9,435.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through December 2025. The contract is for the delivery of GADAVIST 10 MMOL/10 ML VIAL 10ML, a pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.20 firm fixed-price delivery order is for the supply of GADAVIST 10 MMOL/10 ML VIAL 10ML, a medical product. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, with ID SPE2DX15D3005|SPE2DX24F3RFL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of GADAVIST 15 MMOL/15 ML VIAL 15ML, a pharmaceutical product, with a ceiling value of $1,199.49. The contract type is a Delivery Order under a Firm Fixed Price pricing structure, with a completion date of May 3, 2024. Amerisourcebergen Drug Corp, a subsidiary of the...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ94V, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,729.46 firm fixed-price delivery order is for the pharmaceutical product Gadavist 10 mmol/10 ml vial 10 ml. The award has an ultimate completion date of January 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award is for the delivery of GADAVIST 10 MMOL/10 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,165.20 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award date is April 1, 2024, with an ultimate completion date of April 2, 2024. This delivery order is part of a larger indefinite delivery...
This federal contract award, valued at $1,704.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,175,077 units of GADAVIST 1 MMOL/ML BULK VIAL 30ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,731.59 firm fixed-price delivery order is for the supply of GADAVIST 15 MMOL/15 ML VIAL 15ML, a medical imaging product. The contract has an ultimate completion date of September 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...